首页 > 最新文献

DEN open最新文献

英文 中文
Difficult biliary cannulation during endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction caused by pancreatic cancer: An observational study
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-04 DOI: 10.1002/deo2.70092
Jun Noda, Yuichi Takano, Naoki Tamai, Masataka Yamawaki, Tetsushi Azami, Fumitaka Niiya, Naotaka Maruoka, Masatsugu Nagahama

Objectives

Distal malignant biliary obstruction (DMBO) caused by pancreatic cancer often complicates endoscopic retrograde cholangiopancreatography (ERCP), particularly biliary cannulation. While various factors influencing difficult biliary cannulation (DBC) have been studied, data specific to pancreatic cancer-related distant malignant biliary obstruction#x000A0;remains limited. This study identifies factors affecting ERCP success in this patient population to improve clinical outcomes.

Methods

We retrospectively analyzed 119 ERCP procedures for distant malignant biliary obstruction owing to pancreatic cancer with naïve papilla at Showa University Fujigaoka Hospital (January 2020–September 2024). Patient characteristics, duodenal invasion, ampullary bile duct status, papillary morphology, trainee involvement, and adverse events were evaluated. Multivariate analysis identified predictive factors of DBC.

Results

After excluding 17 ERCP failures, 102 patients were analyzed and categorized into non-DBC (n = 40) and DBC (n = 62) groups. The DBC incidence rate was 60.8%. The absence of the ampullary bile duct (odds ratio [OR]: 2.58, 95% confidence interval [CI]: 1.02–6.51; p = 0.04) and the macroscopic appearance of type III papillary morphology (enlarged/protruding; OR: 3.32; 95% CI: 1.07–10.30; p = 0.04) were significantly associated with DBC. Adverse events were slightly more frequent in the DBC group; however, this difference was not statistically significant. Alternative cannulation was performed more often in patients without the ampullary bile duct; however, no difference in adverse events was observed.

Conclusions

The absence of the ampullary bile duct and type III papillary morphology are anatomical risk factors for DBC during ERCP for patients with pancreatic cancer. Early consideration of alternative cannulation techniques or biliary drainage methods may be necessary for such patients.

{"title":"Difficult biliary cannulation during endoscopic retrograde cholangiopancreatography for distal malignant biliary obstruction caused by pancreatic cancer: An observational study","authors":"Jun Noda,&nbsp;Yuichi Takano,&nbsp;Naoki Tamai,&nbsp;Masataka Yamawaki,&nbsp;Tetsushi Azami,&nbsp;Fumitaka Niiya,&nbsp;Naotaka Maruoka,&nbsp;Masatsugu Nagahama","doi":"10.1002/deo2.70092","DOIUrl":"https://doi.org/10.1002/deo2.70092","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Distal malignant biliary obstruction (DMBO) caused by pancreatic cancer often complicates endoscopic retrograde cholangiopancreatography (ERCP), particularly biliary cannulation. While various factors influencing difficult biliary cannulation (DBC) have been studied, data specific to pancreatic cancer-related distant malignant biliary obstruction#x000A0;remains limited. This study identifies factors affecting ERCP success in this patient population to improve clinical outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively analyzed 119 ERCP procedures for distant malignant biliary obstruction owing to pancreatic cancer with naïve papilla at Showa University Fujigaoka Hospital (January 2020–September 2024). Patient characteristics, duodenal invasion, ampullary bile duct status, papillary morphology, trainee involvement, and adverse events were evaluated. Multivariate analysis identified predictive factors of DBC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>After excluding 17 ERCP failures, 102 patients were analyzed and categorized into non-DBC (<i>n</i> = 40) and DBC (<i>n</i> = 62) groups. The DBC incidence rate was 60.8%. The absence of the ampullary bile duct (odds ratio [OR]: 2.58, 95% confidence interval [CI]: 1.02–6.51; <i>p</i> = 0.04) and the macroscopic appearance of type III papillary morphology (enlarged/protruding; OR: 3.32; 95% CI: 1.07–10.30; <i>p</i> = 0.04) were significantly associated with DBC. Adverse events were slightly more frequent in the DBC group; however, this difference was not statistically significant. Alternative cannulation was performed more often in patients without the ampullary bile duct; however, no difference in adverse events was observed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The absence of the ampullary bile duct and type III papillary morphology are anatomical risk factors for DBC during ERCP for patients with pancreatic cancer. Early consideration of alternative cannulation techniques or biliary drainage methods may be necessary for such patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70092","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143554696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple esophageal ulcers in a pediatric case of granulomatosis with polyangiitis: A case report
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-26 DOI: 10.1002/deo2.70089
Yuki Kimura, Takashi Ishige, Takuya Nishizawa, Yoshiko Igarashi, Yoshihito Saito, Ryusuke Yagi, Maiko Tatsuki, Reiko Hatori, Hayato Ikota, Takumi Takizawa

A 14-year-old girl presented with diarrhea and bloody stools was initially diagnosed with infectious colitis and anal fissure. The patient was treated with antibiotics; however, the symptoms persisted and purpura appeared on the patient's lower abdomen. Abdominal computed tomography indicated diffuse wall thickening of the entire colon. A colonoscopy revealed extensive edema, several ulcers, and mucosal friability, resulting in the diagnosis of ulcerative colitis. Blood tests revealed hypoalbuminemia, increased inflammatory marker levels, and high proteinase3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) levels. Urinalysis showed hematuria and casts, raising the suspicion of concurrent vasculitis syndrome. Esophagogastroduodenoscopy revealed multiple punched-out ulcers in the esophagus. Granulomatosis with polyangiitis with gastrointestinal involvement was diagnosed combined with the positive PR3-ANCA results and skin and renal involvement. Steroid therapy was initiated, leading to the rapid improvement of diarrhea, purpura, and esophageal ulcers. While high PR3-ANCA levels are occasionally observed in ulcerative colitis, esophageal ulcers in patients with granulomatosis with polyangiitis often result in poor symptoms. Thus, esophagogastroduodenoscopy should be considered in patients with high PR3-ANCA levels, even in the absence of upper gastrointestinal symptoms.

{"title":"Multiple esophageal ulcers in a pediatric case of granulomatosis with polyangiitis: A case report","authors":"Yuki Kimura,&nbsp;Takashi Ishige,&nbsp;Takuya Nishizawa,&nbsp;Yoshiko Igarashi,&nbsp;Yoshihito Saito,&nbsp;Ryusuke Yagi,&nbsp;Maiko Tatsuki,&nbsp;Reiko Hatori,&nbsp;Hayato Ikota,&nbsp;Takumi Takizawa","doi":"10.1002/deo2.70089","DOIUrl":"https://doi.org/10.1002/deo2.70089","url":null,"abstract":"<p>A 14-year-old girl presented with diarrhea and bloody stools was initially diagnosed with infectious colitis and anal fissure. The patient was treated with antibiotics; however, the symptoms persisted and purpura appeared on the patient's lower abdomen. Abdominal computed tomography indicated diffuse wall thickening of the entire colon. A colonoscopy revealed extensive edema, several ulcers, and mucosal friability, resulting in the diagnosis of ulcerative colitis. Blood tests revealed hypoalbuminemia, increased inflammatory marker levels, and high proteinase3 anti-neutrophil cytoplasmic antibody (PR3-ANCA) levels. Urinalysis showed hematuria and casts, raising the suspicion of concurrent vasculitis syndrome. Esophagogastroduodenoscopy revealed multiple punched-out ulcers in the esophagus. Granulomatosis with polyangiitis with gastrointestinal involvement was diagnosed combined with the positive PR3-ANCA results and skin and renal involvement. Steroid therapy was initiated, leading to the rapid improvement of diarrhea, purpura, and esophageal ulcers. While high PR3-ANCA levels are occasionally observed in ulcerative colitis, esophageal ulcers in patients with granulomatosis with polyangiitis often result in poor symptoms. Thus, esophagogastroduodenoscopy should be considered in patients with high PR3-ANCA levels, even in the absence of upper gastrointestinal symptoms.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70089","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic risk factors to inform early detection of gastric cancer after Helicobacter pylori eradication: Meta-analysis and systematic review
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-26 DOI: 10.1002/deo2.70086
Masaaki Kodama, Osamu Handa, Mitsushige Sugimoto, Takahiro Kotachi, Masaaki Kobayashi, Susumu Take, Shu Hoteya, Katsuhiro Mabe, Takahisa Murao, Ken Namikawa, Takashi Kawai, Kazunari Murakami, Research committee for the Establishment of Risk Evaluation of Gastric Cancer after H. pylori Eradication in Endoscopic Findings, The Japanese Society for Helicobacter Research, Japan

Objectives

Helicobacter pylori eradication reduces but cannot eliminate the risk of gastric cancer (GC). The prevalence of post-eradication GC has been rising. Characterization of the endoscopic findings of post-eradication GC may facilitate its early detection. We performed a meta-analysis and systematic review to clarify endoscopic risk factors to accelerate the early diagnosis of post-eradication GC.

Methods

Medline and PubMed were searched for randomized controlled trials, cohort studies, and case-control studies published in the English-language medical literature between January 1997 and July 2023. The included articles assessed the correlation between post-eradication GC and pre- and post-eradication endoscopic findings, and associated post-eradication GC with gastric atrophy, intestinal metaplasia (IM), map-like redness, and xanthoma.

Results

A total of 963 articles were retrieved. In these articles, 66 papers were finally included, comprising randomized controlled trials, cohort studies, and case-control studies. The included articles addressed gastric atrophy (16 studies), IM (eight studies), map-like redness (six studies), and xanthoma (two studies). Risk ratio (RR) of incident post-eradication GC was 3.40 (95%confidence interval [95%CI]: 1.98–5.84; < 0.001) in cases of severe atrophy, 5.38 (95%CI: 3.62–8.00) in cases of severe IM, 2.34 (95%CI: 1.16–4.68) in cases with post-eradication map-like redness, and 2.75 (95% CI: 1.78–4.26) in cases with xanthoma.

Conclusions

Endoscopic atrophy, IM, and xanthoma observed at pre- and post-eradication time points and post-eradication map-like redness were suggested as endoscopic risk factors for post-eradication GC. Further studies are needed to clarify the risk of post-eradication GC based on these risk factors.

{"title":"Endoscopic risk factors to inform early detection of gastric cancer after Helicobacter pylori eradication: Meta-analysis and systematic review","authors":"Masaaki Kodama,&nbsp;Osamu Handa,&nbsp;Mitsushige Sugimoto,&nbsp;Takahiro Kotachi,&nbsp;Masaaki Kobayashi,&nbsp;Susumu Take,&nbsp;Shu Hoteya,&nbsp;Katsuhiro Mabe,&nbsp;Takahisa Murao,&nbsp;Ken Namikawa,&nbsp;Takashi Kawai,&nbsp;Kazunari Murakami,&nbsp;Research committee for the Establishment of Risk Evaluation of Gastric Cancer after H. pylori Eradication in Endoscopic Findings, The Japanese Society for Helicobacter Research, Japan","doi":"10.1002/deo2.70086","DOIUrl":"https://doi.org/10.1002/deo2.70086","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p><i>Helicobacter pylori</i> eradication reduces but cannot eliminate the risk of gastric cancer (GC). The prevalence of post-eradication GC has been rising. Characterization of the endoscopic findings of post-eradication GC may facilitate its early detection. We performed a meta-analysis and systematic review to clarify endoscopic risk factors to accelerate the early diagnosis of post-eradication GC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Medline and PubMed were searched for randomized controlled trials, cohort studies, and case-control studies published in the English-language medical literature between January 1997 and July 2023. The included articles assessed the correlation between post-eradication GC and pre- and post-eradication endoscopic findings, and associated post-eradication GC with gastric atrophy, intestinal metaplasia (IM), map-like redness, and xanthoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 963 articles were retrieved. In these articles, 66 papers were finally included, comprising randomized controlled trials, cohort studies, and case-control studies. The included articles addressed gastric atrophy (16 studies), IM (eight studies), map-like redness (six studies), and xanthoma (two studies). Risk ratio (RR) of incident post-eradication GC was 3.40 (95%confidence interval [95%CI]: 1.98–5.84; <i>p </i>&lt; 0.001) in cases of severe atrophy, 5.38 (95%CI: 3.62–8.00) in cases of severe IM, 2.34 (95%CI: 1.16–4.68) in cases with post-eradication map-like redness, and 2.75 (95% CI: 1.78–4.26) in cases with xanthoma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Endoscopic atrophy, IM, and xanthoma observed at pre- and post-eradication time points and post-eradication map-like redness were suggested as endoscopic risk factors for post-eradication GC. Further studies are needed to clarify the risk of post-eradication GC based on these risk factors.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70086","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proton pump inhibitor-induced large gastric polyps can regress within 2 months after discontinuation: Experience from two cases
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-26 DOI: 10.1002/deo2.70090
Tomoki Inaba, Kenji Yamauchi, Shigenao Ishikawa, Hugh Shunsuke Colvin, Koichi Izumikawa, Kumiko Yamamoto, Sakuma Takahashi, Masaki Wato, Satoko Nakamura, Seiji Kawano

The long-term use of proton pump inhibitors (PPIs) can induce fundic gland polyps (FPs) in the stomach, sometimes leading to numerous large FPs (LFPs). Although PPI discontinuation can reduce LFP size and number, the underlying process remains unstudied.

A 63-year-old woman on esomeprazole (20 mg daily for 10 years) was scheduled for endoscopic LFP removal. After PPI discontinuation, her LFPs regressed to <10 mm within 35 days. A 60-year-old male physician on rabeprazole (10 mg daily for 12 years) had LFPs detected via esophagogastroduodenoscopy screening. He opted for weekly esophagogastroduodenoscopy with pathological evaluations to monitor changes post-discontinuation.

One week after PPI withdrawal, gastric juice acidity and viscosity increased, with erosion observed on nearly all LFP surfaces. By day 35, all LFPs regressed and resembled sporadic FPs. This study demonstrated that PPI-induced LFPs regress within a short period post-discontinuation and suggests that LFP volume reduction is linked to gastric environment changes, particularly increased acidity.

{"title":"Proton pump inhibitor-induced large gastric polyps can regress within 2 months after discontinuation: Experience from two cases","authors":"Tomoki Inaba,&nbsp;Kenji Yamauchi,&nbsp;Shigenao Ishikawa,&nbsp;Hugh Shunsuke Colvin,&nbsp;Koichi Izumikawa,&nbsp;Kumiko Yamamoto,&nbsp;Sakuma Takahashi,&nbsp;Masaki Wato,&nbsp;Satoko Nakamura,&nbsp;Seiji Kawano","doi":"10.1002/deo2.70090","DOIUrl":"https://doi.org/10.1002/deo2.70090","url":null,"abstract":"<p>The long-term use of proton pump inhibitors (PPIs) can induce fundic gland polyps (FPs) in the stomach, sometimes leading to numerous large FPs (LFPs). Although PPI discontinuation can reduce LFP size and number, the underlying process remains unstudied.</p><p>A 63-year-old woman on esomeprazole (20 mg daily for 10 years) was scheduled for endoscopic LFP removal. After PPI discontinuation, her LFPs regressed to &lt;10 mm within 35 days. A 60-year-old male physician on rabeprazole (10 mg daily for 12 years) had LFPs detected via esophagogastroduodenoscopy screening. He opted for weekly esophagogastroduodenoscopy with pathological evaluations to monitor changes post-discontinuation.</p><p>One week after PPI withdrawal, gastric juice acidity and viscosity increased, with erosion observed on nearly all LFP surfaces. By day 35, all LFPs regressed and resembled sporadic FPs. This study demonstrated that PPI-induced LFPs regress within a short period post-discontinuation and suggests that LFP volume reduction is linked to gastric environment changes, particularly increased acidity.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70090","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic features of gastric neuroendocrine tumors
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-26 DOI: 10.1002/deo2.70088
Katsunori Matsueda, Noriya Uedo, Masanori Kitamura, Takashi Kanesaka, Muneshin Morita, Satoki Shichijo, Akira Maekawa, Yoji Takeuchi, Koji Higashino, Tomoki Michida, Ryu Ishihara, Seiji Kawano, Motoyuki Otsuka

Objectives

The endoscopic features of gastric neuroendocrine tumors (G-NETs) remain unclarified. The present study investigated the endoscopic features of G-NETs in relation to the clinicopathological findings.

Methods

This retrospective study analyzed consecutive patients with G-NETs who received endoscopic or surgical treatment between January 2005 and December 2023. The endoscopic and clinicopathological findings of the lesions were analyzed to provide diagnostic information.

Results

Among 29 patients, the characteristic endoscopic findings of G-NETs on white-light images were reddish color (66%), dilated vessels (83%), submucosal tumor-like marginal elevation (59%), and central depression (48%). The gross appearance of G-NETs was classified into two macroscopic subtypes: reddish polypoid lesions (n = 17) and submucosal tumor-like lesions (n = 9). Magnifying narrow-band imaging endoscopy revealed an absent microsurface pattern plus an irregular microvascular pattern in all cases of reddish polypoid lesions with central depressions (100%, 9/9). The findings of a reddish polypoid lesion and an absent microsurface pattern plus an irregular microvascular pattern corresponded to the subepithelial NET component close to the non-neoplastic surface epithelium. Additionally, reddish polypoid lesions were significantly more frequent in type 1 G-NETs than in type 3 G-NETs (80% vs. 11%, < 0.001), while submucosal tumor-like lesions were significantly more frequent in type 3 G-NETs than in type 1 G-NETs (78% vs. 10%, < 0.001).

Conclusions

These endoscopic features should increase the index of suspicion and help clinicians to correctly diagnose G-NETs through the pathological examination of biopsy specimens.

{"title":"Endoscopic features of gastric neuroendocrine tumors","authors":"Katsunori Matsueda,&nbsp;Noriya Uedo,&nbsp;Masanori Kitamura,&nbsp;Takashi Kanesaka,&nbsp;Muneshin Morita,&nbsp;Satoki Shichijo,&nbsp;Akira Maekawa,&nbsp;Yoji Takeuchi,&nbsp;Koji Higashino,&nbsp;Tomoki Michida,&nbsp;Ryu Ishihara,&nbsp;Seiji Kawano,&nbsp;Motoyuki Otsuka","doi":"10.1002/deo2.70088","DOIUrl":"https://doi.org/10.1002/deo2.70088","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The endoscopic features of gastric neuroendocrine tumors (G-NETs) remain unclarified. The present study investigated the endoscopic features of G-NETs in relation to the clinicopathological findings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective study analyzed consecutive patients with G-NETs who received endoscopic or surgical treatment between January 2005 and December 2023. The endoscopic and clinicopathological findings of the lesions were analyzed to provide diagnostic information.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 29 patients, the characteristic endoscopic findings of G-NETs on white-light images were reddish color (66%), dilated vessels (83%), submucosal tumor-like marginal elevation (59%), and central depression (48%). The gross appearance of G-NETs was classified into two macroscopic subtypes: reddish polypoid lesions (<i>n</i> = 17) and submucosal tumor-like lesions (<i>n</i> = 9). Magnifying narrow-band imaging endoscopy revealed an absent microsurface pattern plus an irregular microvascular pattern in all cases of reddish polypoid lesions with central depressions (100%, 9/9). The findings of a reddish polypoid lesion and an absent microsurface pattern plus an irregular microvascular pattern corresponded to the subepithelial NET component close to the non-neoplastic surface epithelium. Additionally, reddish polypoid lesions were significantly more frequent in type 1 G-NETs than in type 3 G-NETs (80% vs. 11%, <i>p </i>&lt; 0.001), while submucosal tumor-like lesions were significantly more frequent in type 3 G-NETs than in type 1 G-NETs (78% vs. 10%, <i>p </i>&lt; 0.001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These endoscopic features should increase the index of suspicion and help clinicians to correctly diagnose G-NETs through the pathological examination of biopsy specimens.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70088","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143497319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic retrograde cholangiopancreatography and endoscopic cystogastrostomy in very young children (aged <5 years): Feasibility, success, and safety
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-23 DOI: 10.1002/deo2.70085
Ujjal Poddar, Arghya Samanta, Samir Mohindra, Vijay Datta Upadhyaya, Basant Kumar, Anshu Srivastava, Moinak Sen Sarma, Surender Kumar Yachha

Objectives

Paucity of data and concerns about potential lower effectiveness and more adverse events limit the use of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic cystogastrostomy in younger children even in high-volume centers. We retrospectively analyzed indications, success rates, and adverse events of all the children (<18 years) who underwent ERCP and endoscopic cystogastrostomy between January 2010 to May 2024 at our center.

Methods

Data, including patient demographics, indications for the procedure, technical details, and adverse events, were collected from our prospectively kept database and compared according to age groups (<1 year, 1–5 years, 5–10 years, and 10–18 years).

Results

A total of 286 ERCP (273 therapeutic and 13 diagnostic) and 57 endoscopic cystogastrostomy were performed in 222 (138 boys) and 55 children (32 boys), respectively, during the study period with 20% ERCP procedures in under-five children. In children <5 years, the majority of the ERCPs were for biliary diseases (87%), while pancreatic duct procedures (39.5%) were done in higher numbers in children >5 years. For biliary ERCP, choledochal cyst (15, 33%) was the most common etiology in under-five children and choledocholithiasis (60, 34%) in children >5 years. Cannulation and technical success rates were 95% and 92%, respectively with no significant difference across age groups. Adverse events were noted in 36 (16%) with post-ERCP pancreatitis (8%) being the most common. All adverse events were managed conservatively with no mortality.

Conclusion

ERCP can safely be performed in all children, including those under five with various hepato-pancreato-biliary diseases with high technical success rates.

目的 由于数据匮乏以及对潜在的较低有效性和较多不良事件的担忧,即使在高流量中心,内镜逆行胰胆管造影术(ERCP)和内镜膀胱胃造瘘术在低龄儿童中的应用也受到限制。我们回顾性分析了本中心 2010 年 1 月至 2024 年 5 月期间接受 ERCP 和内镜下膀胱胃造瘘术的所有儿童(<18 岁)的适应症、成功率和不良事件。 方法 从我们的前瞻性数据库中收集包括患者人口统计学、手术适应症、技术细节和不良事件在内的数据,并按照年龄组(1 岁、1-5 岁、5-10 岁和 10-18 岁)进行比较。 结果 在研究期间,分别为 222 名儿童(138 名男孩)和 55 名儿童(32 名男孩)实施了 286 例 ERCP(273 例治疗性手术和 13 例诊断性手术)和 57 例内镜下膀胱胃造瘘术,其中五岁以下儿童接受 ERCP 手术的比例为 20%。在 5 岁以下儿童中,大多数 ERCP 是针对胆道疾病(87%),而胰管手术(39.5%)在 5 岁以下儿童中数量较多。就胆道ERCP而言,胆总管囊肿(15例,33%)是5岁以下儿童最常见的病因,而胆总管结石(60例,34%)则是5岁以下儿童最常见的病因。插管成功率和技术成功率分别为 95% 和 92%,各年龄组之间无明显差异。36人(16%)出现了不良反应,其中最常见的是ERCP术后胰腺炎(8%)。所有不良事件均得到保守治疗,无死亡病例。 结论 ERCP 可安全地用于所有儿童,包括患有各种肝胆胰疾病的五岁以下儿童,且技术成功率高。
{"title":"Endoscopic retrograde cholangiopancreatography and endoscopic cystogastrostomy in very young children (aged <5 years): Feasibility, success, and safety","authors":"Ujjal Poddar,&nbsp;Arghya Samanta,&nbsp;Samir Mohindra,&nbsp;Vijay Datta Upadhyaya,&nbsp;Basant Kumar,&nbsp;Anshu Srivastava,&nbsp;Moinak Sen Sarma,&nbsp;Surender Kumar Yachha","doi":"10.1002/deo2.70085","DOIUrl":"https://doi.org/10.1002/deo2.70085","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Paucity of data and concerns about potential lower effectiveness and more adverse events limit the use of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic cystogastrostomy in younger children even in high-volume centers. We retrospectively analyzed indications, success rates, and adverse events of all the children (&lt;18 years) who underwent ERCP and endoscopic cystogastrostomy between January 2010 to May 2024 at our center.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data, including patient demographics, indications for the procedure, technical details, and adverse events, were collected from our prospectively kept database and compared according to age groups (&lt;1 year, 1–5 years, 5–10 years, and 10–18 years).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 286 ERCP (273 therapeutic and 13 diagnostic) and 57 endoscopic cystogastrostomy were performed in 222 (138 boys) and 55 children (32 boys), respectively, during the study period with 20% ERCP procedures in under-five children. In children &lt;5 years, the majority of the ERCPs were for biliary diseases (87%), while pancreatic duct procedures (39.5%) were done in higher numbers in children &gt;5 years. For biliary ERCP, choledochal cyst (15, 33%) was the most common etiology in under-five children and choledocholithiasis (60, 34%) in children &gt;5 years. Cannulation and technical success rates were 95% and 92%, respectively with no significant difference across age groups. Adverse events were noted in 36 (16%) with post-ERCP pancreatitis (8%) being the most common. All adverse events were managed conservatively with no mortality.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>ERCP can safely be performed in all children, including those under five with various hepato-pancreato-biliary diseases with high technical success rates.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70085","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143475416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a novel contrast-enhanced fluoroscopy protocol for endoscopic retrograde cholangiopancreatography in a phantom model (with video)
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-23 DOI: 10.1002/deo2.70087
Takaoki Hayakawa, Masayasu Horibe, Eisuke Iwasaki, Fateh Bazerbachi, Yuki Suno, Tsubasa Sato, Haruka Okada, Yuki Nakajima, Yosuke Mizukami, Atsuto Kayashima, Takashi Seino, Shintaro Kawasaki, Takanori Kanai

Objectives

This study evaluated a novel contrast-enhanced (CE) fluoroscopy protocol for endoscopic retrograde cholangiopancreatography, which optimizes image processing to enhance contrast of devices and contrast media. We compared the CE protocol with the conventional standard protocol to assess its potential for reducing radiation exposure while improving image visibility.

Methods

The study utilized a multidirectional fluoroscopy unit and phantoms to evaluate the new CE protocol against the conventional protocol. Comparisons included radiation dose rates, spatial resolution, and concentration resolution under various fluoroscopic conditions. The investigation aimed to determine if the CE protocol offered improved visibility while potentially reducing radiation exposure.

Results

Three CE protocol modes (LOW-7.5 fps, MID-3.75 fps, and LOW-3.75 fps) achieved lower dose rates than the standard MID-7.5 fps mode commonly used in clinical practice. Dynamic spatial resolution was significantly superior in all three CE modes compared to the standard protocol (p < 0.0167). Static spatial resolution did not differ significantly between protocols. Only the CE MID-3.75 fps mode showed superior concentration resolution compared to the standard protocol (p < 0.00833).

Conclusions

The novel CE fluoroscopy protocol provides superior dynamic spatial resolution in endoscopic retrograde cholangiopancreatopgraphy while reducing radiation exposure, potentially enhancing procedure guidance and safety for both patients and clinicians.

{"title":"Evaluation of a novel contrast-enhanced fluoroscopy protocol for endoscopic retrograde cholangiopancreatography in a phantom model (with video)","authors":"Takaoki Hayakawa,&nbsp;Masayasu Horibe,&nbsp;Eisuke Iwasaki,&nbsp;Fateh Bazerbachi,&nbsp;Yuki Suno,&nbsp;Tsubasa Sato,&nbsp;Haruka Okada,&nbsp;Yuki Nakajima,&nbsp;Yosuke Mizukami,&nbsp;Atsuto Kayashima,&nbsp;Takashi Seino,&nbsp;Shintaro Kawasaki,&nbsp;Takanori Kanai","doi":"10.1002/deo2.70087","DOIUrl":"https://doi.org/10.1002/deo2.70087","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This study evaluated a novel contrast-enhanced (CE) fluoroscopy protocol for endoscopic retrograde cholangiopancreatography, which optimizes image processing to enhance contrast of devices and contrast media. We compared the CE protocol with the conventional standard protocol to assess its potential for reducing radiation exposure while improving image visibility.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study utilized a multidirectional fluoroscopy unit and phantoms to evaluate the new CE protocol against the conventional protocol. Comparisons included radiation dose rates, spatial resolution, and concentration resolution under various fluoroscopic conditions. The investigation aimed to determine if the CE protocol offered improved visibility while potentially reducing radiation exposure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three CE protocol modes (LOW-7.5 fps, MID-3.75 fps, and LOW-3.75 fps) achieved lower dose rates than the standard MID-7.5 fps mode commonly used in clinical practice. Dynamic spatial resolution was significantly superior in all three CE modes compared to the standard protocol (<i>p</i> &lt; 0.0167). Static spatial resolution did not differ significantly between protocols. Only the CE MID-3.75 fps mode showed superior concentration resolution compared to the standard protocol (<i>p</i> &lt; 0.00833).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The novel CE fluoroscopy protocol provides superior dynamic spatial resolution in endoscopic retrograde cholangiopancreatopgraphy while reducing radiation exposure, potentially enhancing procedure guidance and safety for both patients and clinicians.</p>\u0000 </section>\u0000 </div>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70087","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143475417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxygen saturation imaging elucidates tumor heterogeneity in gastric cancer 氧饱和度成像阐明胃癌的肿瘤异质性
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-21 DOI: 10.1002/deo2.70077
Tatsunori Minamide, Nobuhisa Minakata, Riu Yamashita, Shingo Sakashita, Yusuke Yoda, Akihiro Ohashi, Masato Aoshima, Susumu Kobayashi, Tomonori Yano

Oxygen saturation imaging is a new technology that determines biological features from the perspective of oxygen concentration. Therefore, this exploratory study aimed to evaluate the biological implications of oxygen saturation imaging and further assess tumor heterogeneity in gastric cancer. Biopsy samples were selectively obtained from treatment-naïve patients with gastric cancer under real-time oxygen saturation imaging. Tissue oxygen saturation level calculations, immunohistochemistry, and RNA sequencing were performed. The mean tissue oxygen saturation levels at the sampling sites were 32.2%, 70.8%, and 56.2% for hypoxic, hyperoxic, and non-tumor areas, respectively, with significant differences between each pair. CD-31 and glucose transporter 1 protein expression were significantly upregulated in hypoxic tumors. Comprehensive transcriptomic analysis revealed enriched biological processes related to the regulation of insulin-like growth factor transport and uptake by insulin-like growth factor-binding proteins in hypoxic tumors and the type I interferon signaling pathway in hyperoxic tumors. Oxygen saturation imaging has the potential to clarify hypoxia-induced heterogeneity in gastric cancer from both clinical and fundamental perspectives.

{"title":"Oxygen saturation imaging elucidates tumor heterogeneity in gastric cancer","authors":"Tatsunori Minamide,&nbsp;Nobuhisa Minakata,&nbsp;Riu Yamashita,&nbsp;Shingo Sakashita,&nbsp;Yusuke Yoda,&nbsp;Akihiro Ohashi,&nbsp;Masato Aoshima,&nbsp;Susumu Kobayashi,&nbsp;Tomonori Yano","doi":"10.1002/deo2.70077","DOIUrl":"https://doi.org/10.1002/deo2.70077","url":null,"abstract":"<p>Oxygen saturation imaging is a new technology that determines biological features from the perspective of oxygen concentration. Therefore, this exploratory study aimed to evaluate the biological implications of oxygen saturation imaging and further assess tumor heterogeneity in gastric cancer. Biopsy samples were selectively obtained from treatment-naïve patients with gastric cancer under real-time oxygen saturation imaging. Tissue oxygen saturation level calculations, immunohistochemistry, and RNA sequencing were performed. The mean tissue oxygen saturation levels at the sampling sites were 32.2%, 70.8%, and 56.2% for hypoxic, hyperoxic, and non-tumor areas, respectively, with significant differences between each pair. CD-31 and glucose transporter 1 protein expression were significantly upregulated in hypoxic tumors. Comprehensive transcriptomic analysis revealed enriched biological processes related to the regulation of insulin-like growth factor transport and uptake by insulin-like growth factor-binding proteins in hypoxic tumors and the type I interferon signaling pathway in hyperoxic tumors. Oxygen saturation imaging has the potential to clarify hypoxia-induced heterogeneity in gastric cancer from both clinical and fundamental perspectives.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70077","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143455917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of recurrent gastric volvulus successfully treated with nasogastric tube-assisted endoscopic reduction and percutaneous endoscopy-assisted gastropexy
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-21 DOI: 10.1002/deo2.70079
Ryuji Katoh, Eriko Katoh, Hironori Tatsuki, Fumiyoshi Saito, Masahiko Motegi, Kiyotaka Osawa, Hiroshi Saeki

We report the case of a 97-year-old male with recurrent gastric volvulus who was successfully treated with nasogastric tube-assisted endoscopic reduction followed by percutaneous endoscopy-assisted gastropexy with gastric wall fixation. The nasogastric tube facilitates endoscopic reduction by enhancing the procedure's efficiency. In contrast, percutaneous endoscopy-assisted gastropexy provides an effective, minimally invasive method to prevent the recurrence of gastric volvulus, even in patients with poor overall health. This case highlights the clinical utility of these combined approaches in managing gastric volvulus in elderly patients with significant comorbidities.

{"title":"A case of recurrent gastric volvulus successfully treated with nasogastric tube-assisted endoscopic reduction and percutaneous endoscopy-assisted gastropexy","authors":"Ryuji Katoh,&nbsp;Eriko Katoh,&nbsp;Hironori Tatsuki,&nbsp;Fumiyoshi Saito,&nbsp;Masahiko Motegi,&nbsp;Kiyotaka Osawa,&nbsp;Hiroshi Saeki","doi":"10.1002/deo2.70079","DOIUrl":"https://doi.org/10.1002/deo2.70079","url":null,"abstract":"<p>We report the case of a 97-year-old male with recurrent gastric volvulus who was successfully treated with nasogastric tube-assisted endoscopic reduction followed by percutaneous endoscopy-assisted gastropexy with gastric wall fixation. The nasogastric tube facilitates endoscopic reduction by enhancing the procedure's efficiency. In contrast, percutaneous endoscopy-assisted gastropexy provides an effective, minimally invasive method to prevent the recurrence of gastric volvulus, even in patients with poor overall health. This case highlights the clinical utility of these combined approaches in managing gastric volvulus in elderly patients with significant comorbidities.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70079","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143455916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surrounding superficial esophageal cancer masked by Candida esophagitis that was difficult to distinguish from Candida esophagitis alone: A case report
IF 1.4 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-14 DOI: 10.1002/deo2.70080
Shunsuke Takahashi, Mitsuhiro Kono, Yasuhiro Fujiwar

During the initial diagnosis of superficial esophageal squamous cell carcinoma, a 70-year-old man was treated with endoscopic submucosal dissection (ESD). Two years after the first ESD, follow-up endoscopy revealed that the extent of hyperkeratosis gradually expanded over the following 4 years; however, biopsies conducted only detected Candida mycelia and no cancer at that time and every 6 months for 4 years. Despite initiating fluconazole treatment for persistent Candida esophagitis 6 years after the first ESD, the lesions did not resolve, and the second ESD was performed 6 years after the first ESD, which revealed squamous cell carcinoma. This case highlights that esophageal cancer should be considered when localized, hyperkeratotic Candida esophagitis is unresponsive to antifungal treatments, especially with a history of esophageal cancer or high-risk factors such as drinking alcohol and smoking.

{"title":"Surrounding superficial esophageal cancer masked by Candida esophagitis that was difficult to distinguish from Candida esophagitis alone: A case report","authors":"Shunsuke Takahashi,&nbsp;Mitsuhiro Kono,&nbsp;Yasuhiro Fujiwar","doi":"10.1002/deo2.70080","DOIUrl":"https://doi.org/10.1002/deo2.70080","url":null,"abstract":"<p>During the initial diagnosis of superficial esophageal squamous cell carcinoma, a 70-year-old man was treated with endoscopic submucosal dissection (ESD). Two years after the first ESD, follow-up endoscopy revealed that the extent of hyperkeratosis gradually expanded over the following 4 years; however, biopsies conducted only detected <i>Candida</i> mycelia and no cancer at that time and every 6 months for 4 years. Despite initiating fluconazole treatment for persistent <i>Candida</i> esophagitis 6 years after the first ESD, the lesions did not resolve, and the second ESD was performed 6 years after the first ESD, which revealed squamous cell carcinoma. This case highlights that esophageal cancer should be considered when localized, hyperkeratotic <i>Candida</i> esophagitis is unresponsive to antifungal treatments, especially with a history of esophageal cancer or high-risk factors such as drinking alcohol and smoking.</p>","PeriodicalId":93973,"journal":{"name":"DEN open","volume":"5 1","pages":""},"PeriodicalIF":1.4,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/deo2.70080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143423735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
DEN open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1